Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
25. Juni 2020 08:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
10. Juni 2020 13:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
08. Juni 2020 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics® Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program
03. Juni 2020 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture
20. Mai 2020 16:10 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports First Quarter 2020 Results
30. April 2020 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020
23. April 2020 07:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it...
Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results
09. April 2020 16:01 ET
|
Ekso Bionics Holdings, Inc.
- Company Regains Nasdaq Listing Compliance - RICHMOND, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for...
Ekso Bionics® Announces Reverse Stock Split
24. März 2020 16:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced...
Ekso Bionics Reports Fourth Quarter and Year End 2019 Results
27. Februar 2020 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...